Neuroendocrine Tumors
Conditions
Keywords
DT, HADS, SPBS, CD-RISC, Psychosocial Screening
Brief summary
This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety and Depression Scale(HADS), Self-Perceived Burden Scale(SPBS) and Connor-Davidson Resilience Scale(CD-RISC). These assessments will be completed at baseline, 3 months, 6 months, 12 months and 24 months. Patients will have the option of filling out questionnaires more frequently if desired.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
1. sign written informed consent form; 2. age ≥ 18 years; 3. pathologically confirmed well-differentiated neuroendocrine tumors, G1-2 (Ki67≤20%);
Exclusion criteria
1. \<18 years; 2. Neuroendocrine carcinoma; 3. History of psychiatric or psychologic illness; 4. History of previous cancers or cancer distress; 5. Patients with central nervous system(CNS) disorder; 6. Severe, uncontrolled medical condition that would affect patients' compliance;
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| DT | every 3 month until 24 month | Distress Thermometer |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| HADS | every 3 month until 24 month | Hospital Anxiety and Depression Scale |
| SPBS | every 3 month until 24 month | Self-Perceived Burden Scale |
| CD-RISC | every 3 month until 24 month | Connor-Davidson Resilience Scale |
Countries
China